Agenus (AGEN) Cash & Equivalents (QoQ) (2010 - 2026)

Agenus (AGEN) Cash & Equivalents (QoQ) (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Agenus 234.10 Mn 199.10 Mn 33.74 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1,067.31%
Dec 31, 2025 -13.30%
Sep 30, 2025 -63.73%
Jun 30, 2025 -48.43%
Mar 31, 2025 -54.28%
Dec 31, 2024 -9.71%
Sep 30, 2024 -52.22%
Jun 30, 2024 77.32%
Mar 31, 2024 -30.55%
Dec 31, 2023 -28.40%
Sep 30, 2023 -25.77%
Jun 30, 2023 -13.11%
Mar 31, 2023 -7.75%
Dec 31, 2022 -14.24%
Sep 30, 2022 -8.77%
Jun 30, 2022 -7.80%
Mar 31, 2022 -15.15%
Dec 31, 2021 13.80%
Sep 30, 2021 248.81%
Jun 30, 2021 -38.39%